Subependymal giant cell astrocytoma staging: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
|||
Line 19: | Line 19: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] |
Latest revision as of 17:02, 27 November 2017
Subependymal giant cell astrocytoma Microchapters |
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Subependymal giant cell astrocytoma staging On the Web |
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma staging |
Risk calculators and risk factors for Subependymal giant cell astrocytoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
There is no established system for the staging of subependymal giant cell astrocytoma.[1]
Staging
There is no established system for the staging of subependymal giant cell astrocytoma.[1]
References
- ↑ 1.0 1.1 Chandana SR, Movva S, Arora M, Singh T (2008). "Primary brain tumors in adults". Am Fam Physician. 77 (10): 1423–30. PMID 18533376.